Accès ouvert

Phase 2b Open-label Randomized Controlled Trial to Evaluate the Efficacy, Safety and Tolerability of N-acetylcysteine in Reducing Adverse Drug Reactions among Adults Treated for Multidrug-resistant Tuberculosis in Tanzania. (Trial Acronym NAC Trial).

Article scientifique 2021 Anglais

Résumé

Citer ce document

Mpagama, S., Mvungi, H., Mbelele, P., Semvua, H., Liyoyo, A., Guex, K., Sloan, D., Kibiki, G., Boeree, M., Phillips, P., Heysell, S. (2021). Phase 2b Open-label Randomized Controlled Trial to Evaluate the Efficacy, Safety and Tolerability of N-acetylcysteine in Reducing Adverse Drug Reactions among Adults Treated for Multidrug-resistant Tuberculosis in Tanzania. (Trial Acronym NAC Trial).. https://doi.org/10.21203/rs.3.rs-153835/v1

Accès au document

Voir sur le dépôt source

Ce document est hébergé sur son dépôt institutionnel d'origine.

Auteur(s)

Stellah Mpagama Happiness Mvungi Peter M. Mbelele Hadija Semvua Alphonce Liyoyo Kristen Petros de Guex Derek J. Sloan Gibson Kibiki Martin J. Boeree Patrick Phillips Scott K. Heysell

Statistiques

Consultations : 1

Téléchargements : 0